DUBLIN, Dec. 12, 2017 /PRNewswire/ --
The "Continuous Glucose Monitoring (CGM): Technologies and Global Markets" report has been added to Research and Markets' offering.
The Global Market for Continuous Glucose Monitoring Devices and Diabetes-Related Market Should Reach Nearly $12.8 Billion in 2017 and $20.7 Billion in 2022, Registering a CAGR of 10.1%
Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
The scope of this study encompasses the current and forecast markets for glucose monitoring, as well as pumps, SMBG meters and test strips. The covered segments are CGM transmitters, receivers and sensors, patch and durable insulin pumps, and self-monitoring blood glucose (SMBG) equipment and test strips. The test strip market numbers refer to all usage of test strips with SMBG, and not just test strips as used by CGM users. CGM users also use test strips, but theoretically only for calibrating their CGM device.
Calibration may be required once or twice a day, or even less often, as the devices improve in the near future. Inclusion of SMBG meters and test strips will help the reader to comprehend the relative sizes of the two major segments: CGM and SMBG. As discussed elsewhere in this report, developing countries will continue to use primarily SMBG, as these devices are not only much cheaper than CGM, but, for many diabetics, do just fine for monitoring blood glucose.
The report also includes discussions of the reimbursement and regulatory environments, current and developing technologies, diabetes incidence, market projections and market shares, and the latest trends and clinical trials.
Key Topics Covered:
2: Summary and Highlights
3: Market and Technology Background
- History and Current State of Blood Glucose Monitoring Technology
- Working to Improve CGM Technology
- Healthcare Insurance and Reimbursement for CGM Systems and Pumps
- In-depth focus on diabetes
- Global Obesity and the Rise of Diabetes
4: Market Breakdown by Technology Type
- Total Global Market, 2016 Through 2022
- Global CGM Markets
- Global Insulin Pump Markets
- Global SMBG Meters and Test Strips Markets
5: Market Breakdown by Testing Location
6: CGM and SMBG Markets by Type of Diabetes
- CGM Markets by Type of Diabetes
- SMBG and Test Strip Markets, by Type of Diabetes
7: CGM Markets by User's Age
8: Market Breakdown by Region
- Regional Markets for CGMs, Patch Pumps, Durable Pumps, SMBG Meters and Test Strips
- CGM Markets by Region
- Insulin Pump Markets by Region
- SMBG Meters and Test Strip Markets by Region
9: Patent Review/ New Developments
- Patent Review
- New Developments
10: Analysis of Market Opportunities
11: Company Profiles
- Abbott Labs
- Apple Inc.
- Arkray Inc.
- Ascensia Diabetes Care Holdings Ag
- Beta Bionics Inc.
- Bigfoot Biomedical
- Cellnovo Group
- Cequr Sa
- Cnoga Medical Ltd.
- Debiotech S.A.
- Glooko Inc.
- Insulet Corp.
- Intarcia Therapeutics
- Integrity Applications
- Intuity Medical Inc.
- Johnson & Johnson
- Animas Corp. (Jnj)
- Calibra Medical (Jnj)
- Lifescan (Jnj)
- Labstyle Innovations Corp. (Dariohealth Corp.)
- Novo Nordisk
- One Drop
- Senseonics Holdings Inc.
- Sinocare Inc.
- Tandem Diabetes Care
- Unilife Corp.
- Valeritas Inc.
- Ypsomed AG
12: Appendix: CGM and Diabetes-related Device Markets
For more information about this report visit https://www.researchandmarkets.com/research/t279jv/global_continuous?w=5
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets